Zobrazeno 1 - 10
of 53
pro vyhledávání: '"ENNIS, MD"'
Autor:
Philip Sutera, MD, Matthew P. Deek, MD, Rebecca A. Deek, MS, Ozan Cem Guler, MD, Pervin Hurmuz, MD, Mehmet Reyhan, MD, Steven Rowe, MD, PhD, Noura Radwan, MD, Shirl Dipasquale, MSRN, William T. Hrinivich, PhD, Kathryn Lowe, MA, Lei Ren, PhD, Biren Saraiya, MD, Ronald Ennis, MD, Lara Hathout, MD, Tina Mayer, MD, Theodore L. Deweese, MD, Daniel Y. Song, MD, Ana Kiess, MD, Ezgi Oymak, MD, Kenneth Pienta, MD, Felix Feng, MD, Martin Pomper, MD, PhD, Gokhan Ozyigit, MD, Phuoc T. Tran, MD, PhD, Cem Onal, MD, Ryan M. Phillips, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 9, Iss 7, Pp 101507- (2024)
Purpose: Emerging data suggest that metastasis-directed therapy (MDT) improves outcomes in patients with oligometastatic castration-sensitive prostate cancer (omCSPC). Prostate-specific membrane antigen positron emission tomography (PSMA-PET) can det
Externí odkaz:
https://doaj.org/article/919f5deb98734f49825fc1c228a4a377
Autor:
Chirag Modi, MD, Anthony E. Dragun, MD, Clarissa F. Henson, MD, Sheena Jain, MD, Stuti Ahlawat, MD, Gary Eastwick, MD, Gregory J. Kubicek, MD, Megan Mezera, MD, David J. Mulvihill, MD, Jennifer Perri, RN, Badal Juneja, PhD, Karishma Khullar, MD, Ronald D. Ennis, MD, Bruce G. Haffty, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 4, Pp 100704- (2021)
Purpose: Our purpose was to establish the prevalence of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in asymptomatic patients scheduled to receive radiation therapy and its effect on management decisions. Methods and Materials: Betwee
Externí odkaz:
https://doaj.org/article/ef9c6ea18281488f8beb45309140eec9
Autor:
Praveen Pendyala, MD, Alexander G. Goglia, PhD, Malcolm D. Mattes, MD, Alison Grann, MD, David Huang, MD, Raquel T. Wagman, MD, Zeinab Abou Yehia, MD, Jennifer Yoon, MD, Ronald D. Ennis, MD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 3, Pp 100680- (2021)
Purpose: This study aimed to define how the coronavirus disease of 2019 (COVID-19) pandemic affected the role, timing, and delivery of radiation therapy (RT) in a high-prevalence region at the height of the initial U.S. outbreak. Methods and Material
Externí odkaz:
https://doaj.org/article/a0a6b6d1976043c08a5e3c4ec2f54b2d
Autor:
Lara Hathout, MD, Ronald D. Ennis, MD, Malcolm D. Mattes, MD, Raquel T. Wagman, MD, Alison Grann, MD, Salma K. Jabbour, MD, Rachana Singh, MD, Ning J. Yue, PhD, Bruce G. Haffty, MD, Irina Vergalasova, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 1, Pp 100600- (2021)
Purpose: This study aimed to evaluate whether the coronavirus disease of 2019 (COVID-19) pandemic resulted in treatment delays in patients scheduled for or undergoing brachytherapy. Methods and Materials: A retrospective cohort study was conducted ac
Externí odkaz:
https://doaj.org/article/512b21e98efd42e4b61d4492c26a28eb
Publikováno v:
Advances in Radiation Oncology, Vol 2, Iss 4, Pp 615-623 (2017)
Purpose: We retrospectively analyzed late small bowel toxicity in patients who received abdominal or pelvic intensity modulated radiation therapy (IMRT) to the small bowel with a maximum dose greater than the generally accepted maximal tolerable dose
Externí odkaz:
https://doaj.org/article/3e34c173d7b04a938bc696de22a878eb
Autor:
Peter H. Goff, MD, PhD, Louis B. Harrison, MD, FASTRO, Eli Furhang, PhD, Evan Ng, MBBS, FRANZCR, Stephen Bhatia, RTT, Frieda Trichter, DSc, Ronald D. Ennis, MD
Publikováno v:
Advances in Radiation Oncology, Vol 2, Iss 3, Pp 420-428 (2017)
Purpose: The hypothesis is that 2-dimensional kV orthogonal imaging with fiducial markers (kV-FM) and soft-tissue cone beam computed tomography (ST-CBCT) are equally reproducible for daily positional alignments for image guided (IG) intensity modulat
Externí odkaz:
https://doaj.org/article/a800ef001c4b429299c84de4269a67d8
Autor:
STJERNLOF, P, ENNIS, MD, HANSSON, LO, HOFFMAN, RL, GHAZAL, NB, SUNDELL, S, SMITH, MW, SVENSSON, K, CARLSSON, A, WIKSTROM, H
Publikováno v:
Journal of Medicinal Chemistry, 38(12), 2202-2216. AMER CHEMICAL SOC
A series of 1-, 3-, and 4-substituted analogs to the potent 5-HT1A agonist 8-(dipropylamino)-6,7,8,9-tetrahydro-3H-benz[e]indole-1-carbaldehyde (5) were prepared and tested in vitro at 5-HT1A, 5-HT1D alpha, 5-HT1D beta, D-2, and D-3 receptors and in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::70b683f306b10ac8a03dbf4a103fd387
https://research.rug.nl/en/publications/270db756-0ade-4f8f-b5d7-e9963d74156c
https://research.rug.nl/en/publications/270db756-0ade-4f8f-b5d7-e9963d74156c
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.